Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer.

Por Dimitra T Stefanou, Aristotelis Bamias, Hara Episkopou, Soterios A Kyrtopoulos, Maria Likka, Theodore Kalampokas, Stylianos Photiou, Nikos Gavalas, Petros P Sfikakis, Meletios A Dimopoulos, Vassilis L Souliotis
Publicado em 2015-01-01